| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
WA
Based on Analyst Price Targets
Critical Acquisitions And Innovations Fuel Growth In Medical Genetics And Oncology
US$248.27
FV
10.5% undervalued intrinsic discount5.07%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
13 days agoauthor updated this narrative
Labcorp Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$222.22 |
| 52 Week High | US$238.47 |
| 52 Week Low | US$191.97 |
| Beta | 1.04 |
| 11 Month Change | -3.76% |
| 3 Month Change | 6.84% |
| 1 Year Change | 8.32% |
| 33 Year Change | -25.02% |
| 5 Year Change | 34.33% |
| Change since IPO | 811.67% |
Recent News & Updates
When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?
Sep 12
Laboratory Corporation: Difficult To Eye Long-Term Compounding Ability
Sep 11Recent updates
When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?
Sep 12Laboratory Corporation: Difficult To Eye Long-Term Compounding Ability
Sep 11Investors Still Waiting For A Pull Back In Labcorp Holdings Inc. (NYSE:LH)
Jul 20Laboratory Corporation: Limited Upside Visibility, Reiterate Hold
Jun 21When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?
Jun 13Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year
May 08Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72
Apr 30Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72
Apr 15Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark
Apr 06Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear
Apr 01Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72
Feb 25We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings
Feb 22An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued
Feb 21Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72
Jan 31Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 30Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72
Jan 15Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio
Jan 05Laboratory Corporation: Multiple Updates, Same Investment Conclusion
Dec 02Laboratory Corp.: Rate On Capital Deployed Contracting, Hold
Sep 14Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea
Jul 05Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts
Jul 04Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?
Jun 23Laboratory Corporation: Predictability Of Cash Flows Less Visible
Jun 21Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?
May 26Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher
Mar 16Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate
Mar 02Laboratory Corporation of America Non-GAAP EPS of $4.14 in-line, revenue of $3.7B misses by $40M, introduces FY23 outlook
Feb 16Shareholder Returns
| LH | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0.5% | -2.3% | 1.6% |
| 1Y | 8.3% | 10.3% | 30.5% |
Return vs Industry: LH underperformed the US Healthcare industry which returned 10.3% over the past year.
Return vs Market: LH underperformed the US Market which returned 30.5% over the past year.
Price Volatility
| LH volatility | |
|---|---|
| LH Average Weekly Movement | 3.9% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: LH has not had significant price volatility in the past 3 months.
Volatility Over Time: LH's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 61,975 | Adam Schechter | www.labcorp.com |
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests.
Labcorp Holdings Inc. Fundamentals Summary
| LH fundamental statistics | |
|---|---|
| Market cap | US$18.66b |
| Earnings (TTM) | US$449.50m |
| Revenue (TTM) | US$12.49b |
41.5x
P/E Ratio1.5x
P/S RatioIs LH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LH income statement (TTM) | |
|---|---|
| Revenue | US$12.49b |
| Cost of Revenue | US$8.99b |
| Gross Profit | US$3.50b |
| Other Expenses | US$3.05b |
| Earnings | US$449.50m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.35 |
| Gross Margin | 28.00% |
| Net Profit Margin | 3.60% |
| Debt/Equity Ratio | 64.2% |
How did LH perform over the long term?
See historical performance and comparison